Clinical Trials

600 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT07053748 2025-07-08

Observational Clinical Study on High - Risk NMIBC Patients Choosing Trimodality Bladder - Sparing Therapy

Not yet recruiting

30 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT06972771 2025-05-30

Trop2-targeting NIR-II Molecular Probe for Guided Identification of Non-Muscle-Invasive Bladder Cancer

30 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT05002556 2025-04-30

TVNIM-AFU

8,000 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT05945108 2025-04-11

Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER

400 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT05981131 2025-03-13

Follow up of Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive Bladder Cancer (NMIBC)

Active not recruiting

6 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT05864599 2024-04-03

EVALUATION

Active not recruiting

600 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT03973671 2024-03-28

ProCaB

300 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Recurrence, Disease Progression

NCT06245759 2024-02-07

The Prognostic Impact of Tumor Location in Non-Muscle-Invasive Bladder Cancer Patients

120,000 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT06235853 2024-02-01

Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer

240 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Recurrence, Disease Progression

NCT06205277 2024-01-12

START

1,300 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT06020807 2023-09-07

Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder Cancer

168 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT03664258 2023-02-13

ANTICIPATE X

852 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT05508568 2023-02-01

A Performance Evaluation Study of Arquer's MCM5 Elisa Test (ADXBLADDER) to Aid in the Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer

650 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT05675176 2023-01-11

Antegrade Observational Comparative Study for the Intravesical Instillation Therapy of Bacillus Calmette Guerin With the Use of Different Types of Urinary Catheters in Patients With Urinary Bladder Cancer

100 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Fever, Hematuria, Tuberculosis

NCT05337397 2022-08-08

OPTIMA

145 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT05332353 2022-04-18

Machine Learning-Based Prediction of BCG Response in High-Risk Non-Muscle Invasive Bladder Cancer Patients

100 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT04617743 2022-04-12

The Effect of Post-voiding Reisdual Urine on Non-muscle Invasive Bladder Cancer Recurrence and Progression

500 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Recurrence, Disease Progression

NCT03091764 2021-10-13

Evaluation of a Patient-Reported Symptom Index for NMIBC

498 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT02969109 2021-03-02

Validation of a Urine-based Assay With Genomic Markers for Predicting Recurrence for Non-muscle Invasive Bladder Cancer

417 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT04683536 2020-12-24

BUCEAH

106 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT04167332 2019-11-18

ProCSUCaB

Not yet recruiting

630 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Recurrence, Disease Progression

NCT03148158 2018-01-09

Assessment Of Bladder Tumors Stage And Grade By Outpatient Flexible Cystoscopy Performed By Urology Resident

300 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Disease, Pain, Postoperative

NCT01314664 2015-06-12

A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC)

Terminated

15 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT01304173 2014-02-19

Retrospective Chart Review of Valstar

113 enrolled